Save for a few minutes early on in the session, the Switzerland market languished in negative territory on Thursday as investors remained reluctant to make significant moves, digesting the central bank's rate decision, and closely following geopolitical news.
The benchmark SMI ended with a loss of 49.41 points or 0.36% at 13,765.83 after scaling a high of 13,836.55 and a low of 13,743.43 intraday.
Drugmakers Roche (down 2.68%) and Novartis (down 2.45%), were the major losers in the benchmark index. Partners Group drifted down nearly 2%, while Sandoz Group ended 1.6% down.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.